Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date | Activity Code(s) | Title |
---|---|---|---|
PAR-22-233 | March 2, 2025 | R61/R33 | Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) |
RFA-MH-22-245 | October 18, 2024 | UM1 | BRAIN Initiative: Engineering and optimization of molecular technologies for functional dissection of neural circuits (UM1 Clinical Trial Not Allowed) |
PAR-22-224 | May 26, 2025 | R25 | NICHD Research Education Programs (R25 Clinical Trial Not Allowed) |
PAR-23-024 | May 2, 2025 | DP1 | Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) |
RFA-EB-22-002 | June 18, 2025 | R18 | HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) |
NOT-MH-22-290 | January 1, 2027 | Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-22-240, "BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)" | |
NOT-HD-22-041 | January 1, 2027 | Notice of Pre-Application Webinar for the Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) Funding Opportunity Announcements | |
NOT-HD-22-039 | January 1, 2027 | Notice of Upcoming Prize Competition Announcement for the Connecting the Community for Maternal Health Challenge | |
PAR-22-215 | September 8, 2025 | R01 | Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed) |
NOT-HD-22-035 | January 1, 2027 | Notice of Upcoming Prize Competition Announcement for the RADx Tech for Maternal Health Challenge | |
NOT-OD-22-142 | March 17, 2025 | R21 | Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional) |
PAR-22-222 | December 8, 2024 | R01 | Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
NOT-DA-23-007 | July 13, 2025 | K01,K23,R33,R61/R33 | Notice of Special Interest (NOSI): HEAL Initiative: Opioid Use Disorder Care Pathways for Individuals with Histories of Exposure to Violence |
RFA-NS-23-003 | June 10, 2025 | RM1 | HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) |
NOT-NS-23-009 | January 1, 2027 | Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional) | |
NOT-HD-22-037 | January 1, 2027 | Notice of NICHD Participation in RFA-DA-23-051 HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional) | |
NOT-HD-22-027 | January 1, 2027 | Notice of NICHD Participation in NOT-MH-20-110, Collaborative Research in Computational Neuroscience (CRCNS) NSF Innovative Approaches to Science and Engineering Research on Brain Function" | |
NOT-HD-22-031 | January 1, 2027 | Notice of Extension of PAR-20-300, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)" | |
NOT-HD-22-030 | January 1, 2027 | Notice of Extension of PAR-20-299, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)" | |
NOT-HD-22-036 | January 1, 2027 | Notice of Intent to Publish a Funding Opportunity Announcement for ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed) |